PanGen Biotech Inc. (KOSDAQ:222110)
South Korea · Delayed Price · Currency is KRW 4,650.00
+320.00 (7.39%)
At close: Jun 29, 2026
PanGen Biotech Market Cap
PanGen Biotech has a market cap or net worth of 62.84 billion as of June 29, 2026. Its market cap has decreased by -27.46% in one year.
Market Cap
62.84B
Enterprise Value
51.15B
Revenue
13.71B
Ranking
n/a
PE Ratio
31.96
Stock Price
4,650.00
Market Cap Chart
Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 62.84B, a decrease of -63.31%. That is a compound annual growth rate of -9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 62.84B | -16.84% |
| Dec 30, 2025 | 75.57B | 2.79% |
| Dec 30, 2024 | 73.52B | 0.08% |
| Dec 28, 2023 | 73.46B | 5.85% |
| Dec 29, 2022 | 69.40B | -30.44% |
| Dec 30, 2021 | 99.78B | 1.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 77.13B |
| SunBio,Inc. | 76.33B |
| QuadMedicine | 73.83B |
| CTCBIO | 72.68B |
| AriBioLab | 70.92B |
| KoBioLabs | 66.70B |
| Naturalendo Tech | 64.09B |
| ADBiotech | 61.72B |